ClinVar Miner

Submissions for variant NM_000235.4(LIPA):c.482del (p.Asn161fs)

dbSNP: rs762559980
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000667513 SCV000791980 likely pathogenic Lysosomal acid lipase deficiency 2017-06-02 criteria provided, single submitter clinical testing
Invitae RCV000029177 SCV001376981 pathogenic Wolman disease 2023-06-09 criteria provided, single submitter clinical testing This premature translational stop signal has been observed in individual(s) with Wolman disease (PMID: 21963785). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs762559980, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Asn161Ilefs*19) in the LIPA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIPA are known to be pathogenic (PMID: 23485521). ClinVar contains an entry for this variant (Variation ID: 552285). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000029177 SCV000051822 pathogenic Wolman disease 2011-12-01 no assertion criteria provided literature only
Natera, Inc. RCV000667513 SCV002091444 pathogenic Lysosomal acid lipase deficiency 2020-11-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.